Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Mesothelioma, Malignant 2Hearing Loss 2Testicular Neoplasms 1Seminoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Optic Nerve Glioma 1Oligodendroglioma 1Necrosis 1Mesothelioma 1Medulloblastoma 1Gastrointestinal Neoplasms 1Familial ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Astrocytoma 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 7Irinotecan 4Mitomycin 3Leucovorin 3Fluorouracil 3Cisplatin 3Capecitabine 3Trastuzumab 2Interleukin-12 Subunit p35 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2tipifarnib 1sodium thiosulfate 1irinotecan sucrosofate 1entinostat 1dehydroftorafur 1Thalidomide 1Platinum 1Pharmacogenomic Testing 1Mitozytrex 1Interleukin-12 1Floxuridine 1Erlotinib Hydrochloride 1Docetaxel 1Cytoreduction Surgical Procedures 1Cetuximab 1Biopsy 17-hydroxystaurosporine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Appendiceal Neoplasms × sodium thiosulfate × Clear all
NCT04847063 2026-04-14

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
60 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Gastrointestinal Neoplasms, Necrosis, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡